Research programme: alpha V beta X integrin antagonists - DICE Therapeutics
Alternative Names: OralαVßX; αVß1/αVß6 Integrin Antagonist ProgramLatest Information Update: 11 Aug 2023
At a glance
- Originator DICE Therapeutics
- Class Antifibrotics; Small molecules
- Mechanism of Action Integrin alphavbeta1 inhibitors; Integrin alphaVbeta6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Fibrosis